• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comfrey herb tea and hepatic veno-occlusive disease.

作者信息

Ridker P M, McDermott W V

机构信息

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

Lancet. 1989 Mar 25;1(8639):657-8. doi: 10.1016/s0140-6736(89)92154-5.

DOI:10.1016/s0140-6736(89)92154-5
PMID:2564469
Abstract
摘要

相似文献

1
Comfrey herb tea and hepatic veno-occlusive disease.
Lancet. 1989 Mar 25;1(8639):657-8. doi: 10.1016/s0140-6736(89)92154-5.
2
Hepatotoxicity due to comfrey herb tea.
Am J Med. 1989 Dec;87(6):701. doi: 10.1016/s0002-9343(89)80414-0.
3
Comfrey herb tea-induced hepatic veno-occlusive disease.
Am J Med. 1989 Jul;87(1):97-9. doi: 10.1016/s0002-9343(89)80492-9.
4
Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea.
J Pediatr. 1988 Mar;112(3):433-6. doi: 10.1016/s0022-3476(88)80330-5.
5
Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea.
Eur J Pediatr. 1995 Feb;154(2):112-6. doi: 10.1007/BF01991912.
6
Comfrey: assessing the low-dose health risk.
Med J Aust. 1988;149(11-12):678-82. doi: 10.5694/j.1326-5377.1988.tb120821.x.
7
The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment.布加综合征与肝静脉闭塞病。识别与治疗。
Arch Surg. 1990 Apr;125(4):525-7. doi: 10.1001/archsurg.1990.01410160111022.
8
[Veno-occlusive liver disease due to intake of Senecio vulgaris tea].
Gastroenterol Hepatol. 1995 Oct;18(8):413-6.
9
Hepatic veno-occlusive disease and drinking of herbal teas.
J Pediatr. 1989 Oct;115(4):659-60. doi: 10.1016/s0022-3476(89)80308-7.
10
Veno-occlusive disease of the liver secondary to ingestion of comfrey.因摄入紫草科植物而继发的肝静脉闭塞病
Br Med J (Clin Res Ed). 1987 Jul 18;295(6591):183. doi: 10.1136/bmj.295.6591.183.

引用本文的文献

1
Identification of microRNAs Implicated in Modulating Senecionine-Induced Liver Toxicity in HepaRG Cells.鉴定参与调节千里光宁碱诱导的HepaRG细胞肝毒性的微小RNA
Foods. 2022 Feb 12;11(4):532. doi: 10.3390/foods11040532.
2
"Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis."自身免疫（样）"药物和草药诱导的肝损伤：分子发病机制的新见解。
Int J Mol Sci. 2017 Sep 12;18(9):1954. doi: 10.3390/ijms18091954.
3
Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.草药肝毒性：临床特征与列表汇编
Int J Mol Sci. 2016 Apr 27;17(5):588. doi: 10.3390/ijms17050588.
4
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.传统医学与现代医学中的草药肝毒性：实际关键问题与新的鼓舞人心的进展
Front Pharmacol. 2015 Apr 23;6:72. doi: 10.3389/fphar.2015.00072. eCollection 2015.
5
Traditional herbal medicine use associated with liver fibrosis in rural Rakai, Uganda.传统草药使用与乌干达农村拉凯的肝纤维化相关。
PLoS One. 2012;7(11):e41737. doi: 10.1371/journal.pone.0041737. Epub 2012 Nov 27.
6
Metabolism, genotoxicity, and carcinogenicity of comfrey.瑞香狼毒的代谢、遗传毒性和致癌性。
J Toxicol Environ Health B Crit Rev. 2010 Oct;13(7-8):509-26. doi: 10.1080/10937404.2010.509013.
7
Genotoxicity of pyrrolizidine alkaloids.吡咯里西啶生物碱的遗传毒性。
J Appl Toxicol. 2010 Apr;30(3):183-96. doi: 10.1002/jat.1504.
8
Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale).分析大蓝转基因鼠在食用紫草（Symphytum officinale）后肝脏毒性和肿瘤发生与基因表达变化的关系。
BMC Bioinformatics. 2006 Sep 6;7 Suppl 2(Suppl 2):S16. doi: 10.1186/1471-2105-7-S2-S16.
9
Mutagenicity of comfrey (Symphytum Officinale) in rat liver.聚合草（药用聚合草）对大鼠肝脏的致突变性。
Br J Cancer. 2005 Mar 14;92(5):873-5. doi: 10.1038/sj.bjc.6602420.
10
Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats.低剂量贯叶连翘对大鼠毒性作用后肝细胞膜损伤及气泡形成
Int J Exp Pathol. 1993 Apr;74(2):211-7.